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Abstract
Since 2003 when electronic cigarettes (EC) were first introduced to the United States, vaping
has rapidly grown in popularity. Originally advertised as a “healthier” alternative to cigarette
smoking, it has since been proven that vaping has its own detrimental pathophysiologic effects
on the respiratory, cardiovascular, and other organ systems. Additionally, as vaping ingredients
are not fully disclosed, health care providers in general do not have a firm understanding of
what substances lead to what outcomes. This is of particular concern to the anesthesia provider
as perioperatively patients are subject to a multitude of stressors that can cause hemodynamic
instability, an issue that is only further compounded by patient use of unknown inhalants.
Although the American Association of Nurse Anesthetists (AANA) has published
recommendations for anesthetic management of the patient who vapes, it is difficult to translate
the recommendations into practice if patient vaping status is not assessed or understood.
Keywords: vaping, electronic cigarettes, anesthesia, screening checklist
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Enhanced Assessment of Patients Who Vape and Resource Toolkit for Certified
Registered Nurse Anesthetists
Electronic cigarettes (EC) have grown in popularity over the past decade. EC are battery
powered devices used to vaporize a solution of nicotine and other additives into an inhaled
aerosol (Kaisar et al., 2016). Originally advertised as a safe and effective alternative to
cigarettes, ECs have recently been found to negatively affect users’ respiratory and other organ
systems. Vapes, or ECs, contain nicotine and other harmful ingredients that may greatly
increase the risk of complications for a patient undergoing general anesthesia (Hobson et al.,
2020).
The negative effects of cigarette smoking have been studied and reported for many
years. Certified registered nurse anesthetists (CRNAs) understand the perioperative
implications of cigarette use and adapt anesthetic plans accordingly. However, studies have
shown that there is a knowledge gap and many misperceptions when it comes to the overall
health effects of EC use in the surgical patient (Crotty Alexander et al., 2015).
The EC was originally invented by Hon Lik in 2003 (Crotty Alexander et al., 2015). It
was later patented and introduced to the global market in 2007. By 2014, ECs were the most
common tobacco product among American youth. Confirming the rise in popularity, EC use
in high schools rose from 1.5% (220,000 students) in 2011, to 20.8% (3.05 million students)
in 2018 (Cullen et al., 2018). Today use by people of all ages has skyrocketed.
Approximately 3.7% of adults use EC every day. The greatest use, however, is among those
ages 18 to 24 years. About 5.1% of this age group reports using EC daily.
ECs can be helpful for those trying to quit smoking if their vaping leads to complete
cessation of all tobacco product use. However, the use of any form of tobacco product
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particularly among young adults is extremely hazardous. Regular nicotine use can lead to
addiction, not only to nicotine but increases the user’s risk for future addiction to other drugs
as well. Additionally, it can cause harm to the developing brain and the way synapses are
formed (Hobson et al., 2020).
Research has shown that EC use has the potential to cause substantial pulmonary
damage (Crotty Alexander et al., 2015). EC can alter airflow, increase oxidative stress,
interfere with proper lung development, and alter the body’s defense against pathogens. ECs
also have a devastating impact on the cardiovascular system, resulting in hypertension,
hyperlipidemia, and impaired coronary blood flow. Furthermore, EC use and intake of nicotine
can lead to poor tissue oxygenation and subsequent delayed wound healing. (Hobson et al.,
2020).
Needs Assessment
Dr. Cynthia Betron, CRNA and associate director of the Frank J. Tornetta School of
Anesthesia, and Dr. Joan Frizzell, a certified registered nurse practitioner (CRNP) and associate
professor at LaSalle University, endorse our DNP project as a quality improvement initiative. A
letter of support for our DNP project is located at the end of the Appendix. Although the
American Association of Nurse Anesthetists (AANA) has produced strategies for anesthetic
management of electronic cigarette users, it has been acknowledged that anesthetists are failing
to question their patients about vaping prior to surgery (Hobson et al., 2020). With the
implementation of an enhanced preoperative assessment, anesthesia providers will be better
equipped to identify patients vulnerable to general anesthesia complications related to
electronic cigarette use. They can then integrate the recommendations for this patient
population set forth by the AANA into their anesthetic plan of care and improve overall
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perioperative outcomes.
Problem
Considering recent evidence demonstrating the injurious pathophysiologic effects of
vaping, in February 2020, the American Association of Nurse Anesthetists (AANA) published
recommendations for anesthetic management of surgical patients who vape. Suggested
strategies for each perioperative phase include determining the amount of EC nicotine use
during the preoperative stage and avoiding desflurane, a known respiratory irritant, during the
maintenance phase (Hobson et al., 2020).
Despite having references available to craft an anesthetic plan of care for patients who
vape, management plans do not hold their value if EC use is never identified before surgery. A
multitude of reasons may explain why patient vaping status remains undisclosed, beginning
with it has become taboo to admit to vaping (Centers for Disease Control and Prevention
[CDC], 2020). The CDC (2020) stated that “it is difficult for consumers to know what ecigarette products contain” (“About Electronic Cigarettes,” para. #3) and often ECs are used
to deliver marijuana and other drugs. Fearing legal repercussions, patients may be unwilling to
confess to illicit substance use and therefore, might say no when asked if they vape.
Additionally, patients may not realize what they are being asked during the
preoperative assessment, as vaping is also referred to by many other names. Commonly used
terms for EC use include juuling and dabbing, but approximately 20 slang words may be used
to identify vaping. Therefore, it is simply not enough for the CRNA to just ask a patient “Do
you vape?” prior to surgery.
It is routine for anesthesia providers to question patients about cigarette smoking,
identifying how frequently and for how long patients have smoked. CRNAs are less familiar
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with the harmful health effects of ECs and the general anesthesia considerations that coincide
with these pathophysiological changes. Creating a resource toolkit for anesthesia providers
with information regarding the consequences of vaping would increase their knowledge of
these factors, helping CRNAs to better prepare for surgical cases and incorporate questions
about EC use into their preoperative assessment.
Purpose
The dual purpose of this DNP scholarly project is to help anesthesia providers
preoperatively assess patient EC use and to develop a resource toolkit that helps CRNAs
understand the impact of patient vaping on the anesthetic management plan. Vaping presents a
variety of issues throughout the perioperative period and has even been demonstrated to affect
incision apposition in the following weeks after surgery (Hobson et al., 2020). In matters
pertaining to the airway and hemodynamic stability, EC use poses a strong threat to patient
safety. Therefore, it is important that CRNAs perform a thorough preoperative evaluation to
discover patient vaping history and habits, enabling them to deliver a tailored anesthetic plan of
care and provide ideal surgical outcomes. Incorporating questions about vaping into their
preoperative interview would aid CRNAs in detecting patient EC use possibly diminishing the
chance of airway reactivity during intubation and extubation, supporting steady vital sign
parameters throughout the case, and preserving the patient’s overall wellbeing during surgery.
Although approaches to anesthetic management of EC users have already been published,
these methods are probably underused as patient vaping history often goes unrecognized.
Anesthesia providers are well educated on the ramifications of cigarette smoking, which along
with drug and alcohol consumption, are easily detected as questions regarding their use are
already incorporated into the electronic health record. This allows the anesthesia provider to
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modify their anesthetic plan of care by performing actions such as drawing up extra sedation
medications and avoiding certain volatile anesthetics. CRNAs will gain a better understanding of
vaping side effects through materials in the resource toolkit, facilitating the integration of vaping
assessment questions into their preoperative assessments. In instances where patients report EC
use, CRNAs can follow current evidence-based guidelines and make anesthetic modifications
just as they do for patients with other substance use.
Project Questions
1) What is the best scholarly and clinical evidence to support development of a vaping
questionnaire for CRNAs to preoperatively screen patients for potential risks in the
anesthetic plan of care associated with the use of ECs?
2) What is the best scholarly and clinical evidence to develop a resource toolkit for CRNAs
to support their understanding of the adverse consequences of EC use on the airway and
response to anesthesia delivery?
Conceptual Definitions
Vaping is defined as the process of inhaling an aerosolized mist through the mouth,
usually from a battery-operated electronic device (such as an EC) that heats and suspends a
liquid or solid drug or other substance that diffuses into individuals’ bodies. (MerriamWebster, n.d.). Certified Registered Nurse Anesthetists are defined as advanced practice
registered nurses (APRNs) licensed as independent practitioners who plan and deliver
anesthesia, pain management, and related care to patients of all health complexities across the
lifespan (AANA, 2020). According to Yamada et al. (2015), toolkit can be defined as a
packaged grouping of multiple tools and strategies used to educate or facilitate a change in
behavior. Preoperative assessment is defined as a clinical investigation with the goal of
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reducing the patient’s surgical and anesthetic perioperative morbidity or mortality (Zambouri,
2007).
Review of Literature
Search Process
With the increased popularity of ECs, nicotine delivery has changed. In-depth research
regarding the addictive properties and health risks associated with vape use is required for a
better understanding of the implications of these devices. However, there is presently no standard
dosing regimen used in research studies to minimize variables between different
studies. Utilizing the Boolean connector “AND,” the key words “vaping,” “electronic
cigarettes,” “anesthesia,” and “screening checklist” were combined and separated as needed to
elicit optimal search results. The nine databases explored were Summon, Proquest Dissertations
& Theses Global, TRIP, HAPI, PubMed, Cochrane Library, Joanna Briggs Institute EBP
Database, CINAHL, and Medline. The database search yielded a total of 218 possible articles.
Seven of the articles met inclusion criteria and supported the goal of our DNP project. All were
published within the last 5 years.
As vaping is a relatively new issue with limited published research, the empirical
evidence related to our topic comes from animal studies. We also included literature comparing
the effects of EC use to cigarette smoking. Exclusion criteria for article selection consisted of
those discussing the vaping of synthetic cannabinoids, studies on the fetal effects of EC use,
and pediatric exposure to environmental tobacco smoke. The search process is presented in
Appendix 1 and the matrix of systemized literature is presented in Appendix 2. The Johns
Hopkins Nursing Evidence-Based Practice Research Appraisal Tool was used to judge the
evidence level and quality of each publication.
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Empirical Literature
Hobson et al. (2020) examined the anesthesia considerations specific to patients who
use ECs. ECs were advertised as a safe and effective way to reduce the use of traditional
cigarette smoking when they entered the US market in 2007, though statistics have shown that
individuals using ECs for cessation purposes do not stop smoking cigarettes. Instead, they
continue to use both products. Multiple research studies have found that ECs have addictive and
toxic effects from the nicotine and other chemicals they contain. There is a generalized lack of
knowledge regarding the constituents of ECs and their overall health effects. Current literature
suggests that components of vaping devices produce chemicals that can lead to both acute and
chronic multiorgan toxicities. The purpose of this study was to examine published literature
regarding ECs in order to better educate healthcare professionals. Using a meta-analysis design
approach, researchers examined various research studies in order to identify the health effects
of ECs and the potential anesthetic complications. This literature review collected data using
random effect meta-analysis. It included various studies that examined multiple different points
regarding EC use including the ingredients of ECs, the pathophysiologic effects of said
ingredients, perioperative implications, and effective screening techniques.
This review conducted by Hobson et al. (2020) found that there are multiple ingredients
in ECs, including nicotine, propylene glycol acetone, and formaldehyde. When these liquid
elements are heated, they produce aerosolized compounds that have multiple deleterious
effects. In addition to causing damage to one’s lungs, the research found them to also effect the
cardiac, renal, endocrine, and central nervous systems and cause interactions with many of the
anesthetic drugs used during general anesthesia. Researchers found that, when patients are
asked if they smoke, they typically answer “no” because they do not consider the use of ECs as
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smoking. The researchers suggest that a more appropriate question to ask patients is whether
they use any nicotine-containing products, including ECs. A thorough preoperative history and
physical is necessary to create a personalized strategy for anesthetic management. While this
meta-analysis provided a lot of useful information that may be implemented into clinical
practice, there are some limitations to this review. For example, not much information was
disclosed regarding each research study specifically. The quality of each study or clinical trial is
not included in this review. This review has many implications for clinical practice. Authors of
this article included the recommended anesthetic management of EC use. Some interventions
include patient education regarding health implications of vape use as well as information about
smoking cessation. Other interventions are recommended for intraoperative management of
these types of patients and specific monitoring parameters to be vigilant for potential
perioperative complications related to EC use.
Garrett et al. (2021) conducted an animal study to gain a better understanding of the
impact that nicotine-free e-liquid vapor has on general locomotor and mood-disorder related
behaviors. Researchers wanted to determine how vapor puff durations, administration session
length, flavored e-liquid, and sex alter behavior to provide a foundation of administration
parameters that would allow for vapor drug administration with minimal effects on baseline
behavior. Using an experimental study design, experiments were conducted on 334 mice. The
mice were exposed to several nicotine-free vapor pass durations, varying as 1, 3, 6, or 10
seconds, in addition to vapor administrations session lengths of both 10 and 30 minutes.
Afterwards, variables of interest were measured including locomotor activity (LMA), tail
suspension test (TST), and light-dark test. Additionally, the effects of mecamylamine and the
time-course of vapor-induced depression of locomotor activity were assessed. Mice were also
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exposed to flavored vapor inhalation and measured on the same variables. In total, seven
different experiments were conducted: vapor chamber clearance times based on puff duration,
comparison of puff duration and session length on LMA, effects of mecamylamine on vaporinduced depression of LMA, time course of vapor-induced depression of LMA, effects of puff
duration on anxiety-like behavior using the light-dark test, effects of puff duration on
depressive-like behaviors using the tail suspension test, and effects of flavored e-liquid on
LMA, light-dark test, and TST. For the sex comparison and flavor LMA studies, a two-way
mixed factor analysis of variance (ANOVA) was used, with “puff duration” or “treatment
condition” as within-subjects factors and “sex” or “flavor” as between-subjects factors. The
light-dark test and TST sex comparison studies utilized two-way between-subjects ANOVAs,
with “sex” and “puff duration” as between-subject factors. One-way between-subjects
ANOVAs were used for the chamber clearance, time course, and light-dark test and TST flavor
studies. All significant ANOVAs were followed by a Tukey post hoc test (significant set at p <
0.05).
Garrett et al. (2021) then recorded the findings of the various experiments conducted in
this study. Vapor chamber clearance is an important variable to report because it determines how
long a subject is exposed to the vapor being studied. Puff duration significantly increased the
time needed for the vapor to completely clear the passive vapor chamber. The 10 second puff
took an additional 90 seconds to clear the vapor when compared to the 1 second puff. Following
both the 10- and 30-minute vapor administration sessions, there was a puff duration-dependent
decrease in distance traveled, time in center, and rearing. The vapor-induced depression of
locomotor activity was not mediated by nicotine or nicotinic acetylcholine receptor activation
and lasted 60-90 minutes. The 10 second puff duration led to anxiogenic-like effects in the light-
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dark test by decreasing the time spend in the light side. Vapor inhalation did not significantly
alter tail suspension test behavior. No significant effects of sex or flavor were found. The
findings of this study demonstrate that vapor puff duration but not necessarily vapor
administration session length, is an important variable to consider during future research design
as it can become a confounding variable and alter other baseline behaviors. The anxiogenic-like
effects of nicotine-free vapor inhalation are concerning because many adolescents vape nicotinefree flavored e-liquid. These behavioral changes could mask or enhance drug effects, limiting
our ability to translate these results to the clinical population. There is also an association
between ECs and mood disorders. This could be concerning to healthcare providers because EC
use may exacerbate anxiety in individuals with existing mood disorders. There are some
limitations to this research study. It did not examine how the addition of nicotine or repeated
administration would alter the anxiogenic-like effects produced by nicotine-free vapor
inhalation. Future studies should be conducted to determine how e-liquids containing nicotine
concentrations alter the anxiogenic-like and repression of LMA. There is also a lack of
standardization of dosing regimens across research groups. This prevents proper replication
between laborites. Standardizing total vapor exposure or vapor clearance times would provide
consistency across laboratories and standardize drug dosing for animals. As of now, variability in
vapor administration parameters still exists, making it difficult to compare results between
laboratories and various research studies. While many people may perceive ECs and nicotinefree vapes as a safer alternative to traditional cigarettes, this research has shown that these
products are far from harmless (Garrett et al., 2021).
The goal of Wawryk-Gawda et al. (2020) was to evaluate histopathological damage
following conventional cigarette and EC exposure. Thirty male Wistar rats of average body
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weight were divided into three groups. Group A was exposed to scent free, nicotine containing
EC liquid vapor, Group B was exposed to conventional cigarette smoke, and Group C was
subjected to similar inhalational stress but without a nicotine component. The groups were
exposed over the course of 6 weeks with a 10-minute exposition occurring 5 consecutive days
per week. Following their last exposition, the rats were decapitated, and their organs were
embedded in paraffin blocks allowing researchers to then perform histomorphological
evaluation of the tissues via different types of staining.
Although more severe detrimental pathological changes like emphysema and fibrosis
were seen in the lungs of rats exposed to conventional smoke, significant bronchial
hemorrhage, alveolar septa thickness, and eosinophil and macrophage lung infiltration was also
observed in the group of rats exposed to EC vapor. These alterations ultimately contribute to
hindered gas exchange, proving that exposure to nicotine in the form of ECs is still disruptive to
lung tissue structure. Limitations of the study included that it was conducted over a relatively
short period of time and only male rats were included for homogeneity (Wawryk-Gawda et al.,
2020).
Similarly, Chun et al. (2017) summarized the evidence of pulmonary toxicity seen in
cell cultures, animal models, and human subjects from numerous studies. While the
methodology used to uncover existing research was unclear, the authors provided a
comprehensive summary of the data documenting respiratory injury due to vaping including
increased airway hyperreactivity and resistance and decreased antimicrobial activity.
Limitations for the studies evaluated were the wide range of variables involved, lack of
longitudinal information, and the need for the standardization of research approaches (Chun et
al., 2017).
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EC or vape use in adolescents has become a true public health crisis that impacts the
perioperative care of this population. ECs have quickly become the most used tobacco products
among youth in the United States. Rusy et al. (2021) set out to conduct a thorough analysis of
multiple research studies that examine the impact vaping has on adolescents in the perioperative
setting. One study involved in this review looked at the numerous brands of vaping devices that
exist. They found over 460 different brands marketed with trendy names and flavor additives,
such as fruit or mint, specifically targeting children and teens. Vaping products may have
significantly higher nicotine levels compared to traditional cigarettes. Unfortunately, no
consensus exists on how the strength of nicotine in these products is reported. At least one
study has determined that ECs are less irritating during use compared to the FDA-approved
nicotine inhalers for smoking cessation. The availability of flavors for ECs, in addition to less
noticeable irritation with possible higher inhaled nicotine levels, makes these products much
more attractive to youth and young adults, possibly leading to an increased risk of long-term
nicotine addiction (Rusy et al., 2021).
This review showed that there is valid evidence demonstrating the benefits of
preoperative and long-term postoperative smoking cessation. It is important that the topic of
smoking cessation and the perioperative risks associated with continued EC use are discussed in
the anesthesia preoperative screening clinic. Given the relatively recent introduction of vaping,
there is very little evidence available to guide the intraoperative management of patients who
vape. A review of current vaping prevention programs identified a knowledge gap and lack of
evidence–based tools available to inform adolescents about EC use risks. Rusy et al. (2021)
recommend future studies focusing on postoperative outcomes of patients with regard to
smoking and vaping use. Because EC use is relatively new, the long-term health impact is
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unknown. As part of a preanesthetic evaluation, anesthesia providers should identify those who
are most at-risk and adjust their plan of care accordingly. The continued education of the public
and healthcare providers alike regarding vaping, nicotine use, and perioperative risks is strongly
encouraged.
Harris and Foley (2020) also appraised both experimental and qualitative studies to
determine the potential implications of vaping on anesthetic and surgical outcomes. This was
done by performing a PubMed search using the key words “ENDS” or “electronic cigarettes”
alone or in combination with “health effects,” “anesthesia,” “surgery,” “injury,” and “smoking
cessation.” In addition, by performing a meta-analysis of 93 cases occurring between 2016 and
2018 the authors verified the main demographic group and site of injury for those who
experienced fires and explosions from electronic nicotine delivery system (ENDS) use.
Predictably, given the growing number of youths who vape, young male EC users
sustained the greatest number of burn injuries primarily to their thighs and hands. Identified
cardiovascular and pulmonary findings were paired with subsequent recommendations for
perioperative management by the authors, with the primary suggestion being to add explicit
questions about ENDS use to preanesthesia interview questionnaires (Harris & Foley, 2020).
At the 2020 American Society of Anesthesiologists (ASA) annual meeting two
anesthesia providers presented the results of a survey they conducted at their institution. The
survey went out to all anesthesiologists, anesthesia residents, CRNAs, and student registered
nurse anesthetists (SRNAs) and asked 10 questions assessing their knowledge of vaping effects,
how they ask patients about vaping, and how this information changes their anesthetic
management. Nearly half the respondents said they do not ask about vaping use at all in the
perioperative period, despite almost 90% of them feeling that patient vaping status is important
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to know about. Only 11% of respondents believed they were knowledgeable on the subject.
This information indicates that most providers are still not routinely assessing for EC use and
that there is a large knowledge gap in management of this patient population (Strunk &
Hendren, 2020).
Theoretical Literature
Anesthesiologist, Dr. John Oyston, too promotes the preoperative assessment of vaping
and published an opinion piece outlining what he believes is the best way to discuss EC use
with patients before surgery. Part of his method includes not just using one term to ask about
vaping but also addressing it by its other popular names such as “JUULing”, and as an opening
question asking what flavor patients use as “this is also a fairly neutral and non-threatening
question that may open up dialogue” (Oyston, 2020).
Summary
Further research is necessary to fully understand the negative impacts and addictive
potential ECs pose. With the increase in popularity of EC use and the various types of vaping
products, the way nicotine is delivered or administered has been altered. Thus, there is no
standard that exists for dosing regimens for clinical research, and most of the existing
information available is derived from animal studies. Garrett et al. (2021) and Wawryk-Gawda
et al. (2020) exposed mice and rats to various amounts of EC vapor to establish the anxiogenic
effects and histopathological damage caused by vaping. Chun et al. (2017) also incorporated
animal model studies into their review that demonstrated significant pulmonary toxicity from
EC exposure. Potential longitudinal studies will be more valuable following methodology and
variable standardization and are crucial for regulation of these products and directing health
care professionals in their management of this patient population.

19
In addition to the need for future studies, another common theme identified was a lack
of anesthesia provider assessment of patient EC use. Most of the sample of anesthesia providers
surveyed by Strunk and Hendren (2020), admitted that their current practice did not include
routinely assessing patients for vaping. Hobson et al. (2020), Rusy et al. (2021), Harris and
Foley (2020), and Oyston (2020) all recommend incorporating specific questions about vaping
into the preanesthetic assessment.
The physiological changes accompanied with EC use are evident and it is the everyday
job of the anesthesia provider to address them and deliver an anesthetic appropriately tailored to
patient comorbidities and conditions. Governing bodies, including the AANA have recognized
the pathophysiologic implications of vaping and published the currently best-known
perioperative management strategies for the surgical patient who vapes. Despite having this
information available it is likely underutilized and patients who use ECs are not being optimally
managed, as vaping status is frequently not asked about and therefore not recognized.
Conventional cigarette smoking, drug use, and alcohol use are already integrated into the
electronic health record and discussing them is a fundamental part of the anesthesia providers
preoperative interview with the patient. Developing a resource toolkit will improve CRNA
knowledge about the anesthetic implications of EC use and reinforce the benefit of including
questions about vaping into their preanesthetic workup.
Related Content
Rather than simply creating a list of vaping-related questions to ask the patient, bundling
evidence-based resources as part of a toolkit promotes the addition of vaping questions into the
CRNAs current preoperative assessment. Changes to clinical practice can be met with
resistance due to being unfamiliar with a problem.
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In a study conducted by Hwang et al. (2020), several different groups of health care
professionals including resident and attending physicians were interviewed about their
perspectives on EC use and its health implications. The authors found that despite a growing
body of evidence documenting the increasing prevalence and adverse consequences of vaping,
familiarity with this information was low across all groups, highlighting the need for
incorporation of this topic into the medical education curriculum (Hwang et al., 2020).
Yamada et al. (2015) propose that “'Evidence-based toolkits can be used to facilitate
practice change, and can include strategies for guideline implementation.” Resource toolkits
incorporate a variety of materials conveying evidence on a topic and allow users to choose and
review them at their own discretion (Yamada et al., 2015). Making the information regarding
the harmful pathophysiologic effects of vaping easily accessible to anesthesia providers
increases the likelihood that they incorporate questions about electronic cigarettes into their
preoperative assessment and deliver an anesthetic based on AANA guidelines.
Theoretical Framework
Duffy’s Quality-Caring Model (2005) is a middle-range theory that describes the two
primary relationships that make up professional encounters. Foremost is the nurse-patient
relationship, followed by all other responsibilities shared with the nurse by other healthcare
team members. Duffy established that, by strengthening the quality of relationships in acute
care, more desirable patient outcomes persevere. According to Duffy (2005), when nurses
cultivate a caring relationship with patients, they “are more willing to share, work
together, change old patterns, and adhere to new regimens” (p.4). The surgical patient who
vapes has a greater likelihood of trusting and establishing a rapport with an anesthesia provider
who is knowledgeable about the pathophysiological changes incurred with EC use and asks
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questions in a non-judgmental way. By implementing Duffy’s Quality-Caring Model, CRNAs
can perform a safety-focused, comprehensive anesthesia workup inclusive of patient vaping
habits. An effective preoperative assessment, involving questions about electronic cigarette use,
together with a healthy and supportive nurse-patient relationship, could help to greatly improve
outcomes for surgical patients receiving anesthesia.
Methods
Design
Quality improvement projects serve to not only recognize and address problems within
the healthcare system but empower clinicians as well. Following an extensive database search,
we were able to review existing empirical literature documenting pathophysiologic damage due
to EC use. Additionally, we examined theoretical publications summarizing lack of anesthesia
provider awareness of identifying and managing the surgical patient who vapes. By preparing
an enhanced vaping assessment, anesthesia providers are more likely to provide the most
optimal anesthetic and maintain patient safety and satisfaction. Simultaneously supplying
CRNA’s with a resource toolkit detailing the side effects of electronic cigarettes and
corresponding anesthetic implications encourages adopting the enhanced vaping assessment
into practice.
The program planning matrix, featured in Appendix 3, provides structure to our DNP
project, and offers strategies to develop an enhanced preoperative screening to better identify
vaping use and at-risk patients. The program planning matrix begins by defining the program
goals. This includes both our DNP project specific goal and an overall impact goal related to
reducing the risk of perioperative complications. The matrix then continues to detail short-term,
intermediate-term, and long-term objectives. Also listed are the proposed methods and
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techniques used to achieve said objectives and the timelines for completion. As project
directors, we are the responsible personnel for each objective, with expert consultation from
project team members Dr. Cynthia Betron and Dr. Joan Frizzell.
Sample and Setting
The first sample for our DNP project is a thorough evaluation of the literature
establishing the negative repercussions of vaping and insufficient anesthesia provider awareness
on how to best manage this patient population. The second sample is an expert panel comprised
of reviewers with more than one year of experience who routinely review patient readiness for
surgical procedures. Anesthesiologists and CRNA’s are key stakeholders and were selected to
appraise our screening tool. Distribution of the enhanced vaping assessment and resource
toolkit will take place within FJTSA clinical settings such as Einstein Medical Center
Montgomery (EMCM).
Ethical Considerations
Institutional Review Board (IRB) exemption was solicited as our DNP quality
improvement project does not meet the criteria for human subjects research. Patient consent,
incentives, anonymity, confidentiality, and data storage and destruction do not need to be
addressed at this time. A letter of the IRB exempt status is located after the appendix.
Instrument
The expert reviewer content form in Appendix 5 serves as our DNP project instrument.
The form contains questions based on directed content analysis of the literature detailed in
Appendix 6.
Procedures for Data Collection
First, the literature was appraised to guide the initial draft of the enhanced vaping
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assessment. We used predetermined codes to identify relevant text and craft questions. Utilizing
Qualtrics online survey software, the expert panel was then emailed the expert reviewer content
form featuring a 4-point scale and comment box next to each question to provide quantitative
and qualitative responses. An example of this can be found in Appendix 7.
Results
Utilizing the approach for assessing content validity outlined by Polit and Beck (2017),
we calculated each item content validity index (I-CVI) and scale content validity index (SCVI). An I-CVI of .80 or above was considered an acceptable value and our item I-CVI’s
ranged from 0.75 to 1.0, detailed in Appendix 8. Our computed S-CVI was 0.87, indicating
overall excellent content validity (Polit & Beck, 2017).
Discussion
Content validation of our enhanced assessment questions and positive comments from
the expert panel clearly demonstrate the relevance of evaluating patient vaping status prior to
administering anesthesia. The single limitation to our project was the small number of experts
who responded to our survey as larger groups are preferable (Polit & Beck, 2017).
There has been ASA acknowledgement that “patients may be ingesting dangerous
vaping products and that this information may be important to consider before surgery”
(Feinstein & Katz, 2020). Similarly, the AANA has stated that “anesthesia providers need to be
aware of the deleterious health effects of EC and the considerations for patients undergoing
general anesthesia,” and gone so far as to publish strategies for anesthetic management of EC
users (Hobson et al., 2020). We are confident that presenting our validated enhanced
assessment questions alongside a resource toolkit will encourage anesthesia providers to
integrate screening patients for vape use into their practice.
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In the future it is our hope that upcoming cohorts can build upon our enhanced vaping
assessment by studying anesthetic outcomes of patients who are routinely asked these
questions. Over a predetermined time, surgical patients at EMCM might be asked our five
expert validated questions and retrospective analysis could occur to determine trends in
provider management strategies and patient safety and satisfaction. We predict that anesthetic
providers would select better volatile agents, opioids, and neuromuscular blockers, as well as
time airway manipulation more appropriately, as a direct result of conducting our enhanced
vaping assessment.
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Appendix 1
Search Process Review of Literature
Database

Total
Articles

Summon
ProQuest
Dissertations &
Theses Global
TRIP
HAPI
PubMed

104
1

Cochrane
Library
Joanna Briggs
Institute EBP
Database

44
3
24

14
10

CINAHL

7

Medline

11

Search Process Review of Literature
Articles
Articles
Articles
Remaining
Remaining
Retrieved and
After Title
After Abstract
Examined
Review
Review
15
11
11
0
0
0

Articles that
fit Inclusion
Criteria
4
0

1
0
10 (Not
including 5
duplicate
articles
removed)
1

1
0
7

1
0
7

0
0
1

0

0

0

2 (Not
including 1
duplicate
article
removed)
0 (Not
including 2
duplicate
articles
removed)
0 (Not
including 2
duplicate
articles
removed)

1

1

1

0

0

0

0

0

0
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Appendix 2
Systematized Literature Review Matrix
Database #
Article
First Author,
Year (full
citation in
References)

Purpose of Study

Summon,
Article #1,
Garrett, 2021

The purpose of this
study was to gain a
better understanding
of the impact that
nicotine-free eliquid vapor has on
general locomotor
and mood-disorder
related behaviors.
The researchers also
wanted to determine
how vapor puff
durations,
administration
session length,
flavored e-liquid,
and sex alter
behavior to provide
a foundation of
administration
parameters that
would allow for
vapor drug

Major Variables
(IV, DV) or
Phenomenon

Theory or
Conceptual
Framework

Design

Measurem
ent Major
Variables
(Instrume
nt)

Data Analysis
(Name of
Statistics,
descriptive,
Inferential and
Results)

Findings

Evidence
Level of
Research &
Quality
Johns
Hopkins
Nursing
EvidenceBased
Practice

Not indicated

Experimental

N/A

For the sex
comparison and
flavor LMA
studies, a two-way
mixed factor
analysis of variance
(ANOVA) was
used, with “puff
duration” or
“treatment
condition” as
within-subjects
factors and “sex” or
“flavor” as
between-subjects
factors. The lightdark test and TST
sex comparison
studies, two-way
between-subjects
ANOVAs were
used, with “sex”
and “puff duration”

The findings of this
study found that
nicotine-free vapor
inhalation altered
some, but not all
behaviors, and these
behavioral changes
could mask or
enhance drug
effects, limiting our
ability to translate
these results to the
clinical population.

Level I B
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administration with
minimal effects on
baseline behavior.

Summon,
Article #2,
WawrykGawda, 2021

PubMed,
Article #1,
Chun, 2017

This study sought to
determine if the l
histopathological
damage seen with
cigarette smoking is
also incurred with
EC use. The
independent
variables were
conventional
cigarette exposure,
EC exposure, and
non-exposure to any
nicotine delivery
system. The
dependent variable
was lung tissue
alteration.
Evidence was drawn
from biological and
clinical studies

Not indicated

Experimental

Not indicated

Scoping
review

as between-subject
factors. One-way
between-subjects
ANOVAs were
used for the
chamber clearance,
time course, and
light-dark test and
TST flavor studies.
All significant
ANOVAs were
followed by a
Tukey post hoc test
(significant set at p
< 0.05).
Measurem The Shapiro-Wilk
ent values
test was used to
included
assess data
histologica distribution and the
l stains as
Kruskal-Wallis test
well as
was used to
some
calculate P-values
biochemica with a probability
l and
less than 0.05
molecular
considered to be
markers by statistically
ELISA.
significant.

N/A

Evidence synthesis

The histological
structure of the
lungs of the EC and
conventional
cigarette groups
exhibited numerous
pathological
changes, with more
significant
destruction seen in
the conventional
cigarette group.

Level 1 B

There is quickly
mounting evidence
from in vitro,

Level I B
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documenting the
pulmonary toxicity
profile of EC use.

Joanna Briggs
Institute EBP
Database,
Article #1,
Rusy,2021

Electronic cigarette
or vape use in
adolescents has
become a true public
health crisis that
impacts the
perioperative care of
this particular
population. Authors
of this article set out
to conduct a
thorough analysis of
multiple research
studies that examine
the impact vaping
has on adolescents
in the perioperative
setting.

Not indicated

MetaAnalysis

N/A

Random effects
meta-analysis

animal, and human
studies that ECs
impact respiratory
function, however
further research is
necessary to help
shape regulatory
standards and close
gaps in our
understanding.
This review showed
that there is valid
evidence
demonstrating the
benefits of
preoperative and
long-term
postoperative
smoking cessation.
It is important that
the topic of smoking
cessation and the
perioperative risks
associated with
continued electronic
cigarette use are
discussed in the
anesthesia
preoperative
screening clinic.
Given the relatively
recent introduction
of vaping, there is
very little evidence
available to guide
the intraoperative

Level II B
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Summon,
Article #3,
Harris, 2020

The authors
compiled the results
from a PubMed
search on electronic
nicotine delivery
systems (ENDS) and
determined possible
effects from ENDS
use that could
influence anesthesia
and surgical
outcomes.

Summon,
Article #4,
Hobson, 2020

There is a
generalized lack of
knowledge
regarding the overall
health effects of
electronic cigarettes.
The current
literature that does
exist suggests that

Not indicated

MetaAnalysis

N/A

Random effects
meta-analysis

Meta analysis

N/A

Random effects
meta-analysis

management of
patients who vape.
A review of current
vaping prevention
programs identified
a knowledge gap
and lack of evidence
–based tools
available to inform
adolescents about
electronic cigarette
use risks.
ENDS use poses
serious perioperative
risk factors and
needs to be
identified prior to
surgery. With the
increasing number
of users it is likely
for anesthesia
providers to take
care of this patient
population and they
should be aware of
care
recommendations.
This review found
that there are
multiple systems
negatively affected
by the use of
electronic cigarettes,
including the
pulmonary, cardiac,
and central nervous

Level III B

Level III B
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components of
vaping devices
produce chemicals
that can lead to both
acute and chronic
multiorgan
toxicities.
Researchers
examined various
research studies in
order to identify the
health effects of
electronic cigarettes
and the potential
anesthetic
complications.

system. Researchers
found that, when
patients are asked if
they smoke, they
typically answer
“no” because they
do not consider the
use of electronic
cigarettes as
smoking. The
researchers suggest
that a more
appropriate question
to ask patients is
whether they use
any nicotinecontaining products,
including electronic
cigarettes. A
thorough
preoperative history
and physical is
necessary in order to
create a personalized
strategy for
anesthetic
management.
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Appendix 3
DNP Project Timeline
Tasks to Complete

Aug 2021 Oct 2021 Nov 2021

Identify DNP Project Committee

X

Prepare DNP project Proposal

X

X

Submit Proposal to La Salle IRB

X

Assessment/Toolkit Development
Expert Review
Revisions and Edits

Feb 2022 March 2022 April 2022

X

X

X

X

X

X

X

Assessment/Toolkit Finalization

X

Complete DNP Project Paper

X

Project Defense

May 2022

X

Prepare Proposal PowerPoint

Proposal Defense

Jan 2022

P
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Appendix 4
Program Planning Matrix

DNP Project Specific Goal:
Identify electronic cigarette use in surgical patients through an enhanced assessment. Provide a resource toolkit to facilitate
CRNA acceptance of process change.
Overall Impact Goal:
Appropriately tailor an anesthetic plan of care for the surgical patient who vapes based on recommendations from the American
Association of Nurse Anesthetists (AANA) to reduce perioperative complications related to vape use.
Objectives
Methods and Techniques Timeline Resources
Responsible
Outcomes
Personnel
Short Term Objectives
1. Perform a needs Identify the problem
Fall 2020 Clinical experts
Erika Dlugosz Need for preoperative
through discussions with
Dr. Cynthia
and Lindsay
assessment of vaping
assessment.
anesthesia providers and
Betron and Dr.
Gregg
identifiedFrank J. Tornetta and La
Joan Frizzell
Salle faculty, as well as
1. Electronic cigarette use
personal clinical
is frequently unreported
experiences.
prior to surgery.
2. Electronic cigarette use
has detrimental
pathophysiologic effects
on respiratory,
cardiovascular, and other
organ systems that
contribute to
hemodynamic instability
under general anesthesia.
3. AANA guidelines exist
for anesthetic
management of the
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patient who vapes but are
likely underutilized as
patient vaping status often
goes undisclosed.
2. Conduct a
search of
relevant
literature.

Access scholarly
databases for empirical
and theoretical literature
pertaining to anesthesia
and vaping.

Summer
2021

Academic
databases

Erika Dlugosz
and Lindsay
Gregg

Literature findings in
support of the need for an
enhanced preoperative
assessment of the surgical
patient who vapes.
Refer to Appendix 1.
No standardized
preoperative assessment
for vaping exists leaving
this patient population at
risk for failure to receive
the most optimal
anesthetic plan of care.

Intermediate-Term Objectives
1. Analyze
evidence level
of research and
quality.

Utilize appropriate
evidence appraisal tool to
determine quantitative vs.
qualitative evidence.

2. Complete a
content analysis
of relevant
literature.

Systematically evaluate
articles meeting inclusion
criteria and in support of
our DNP project.

Summer
2021

Fall 2021
to Spring
2022

Johns Hopkins
Nursing
Evidence-Based
Practice Research
Evidence
Appraisal Tool
Scholarly articles

Erika Dlugosz
and Lindsay
Gregg

Level and quality of each
piece of evidence
appraised.
Refer to Appendix 2.

Erika Dlugosz
and Lindsay
Gregg

Refer to Appendix 6.
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3. Develop an
enhanced
preoperative
assessment of
the surgical
patient who
vapes.

Consult with clinical
experts to formulate a
focused preoperative
assessment to identify and
evaluate patient electronic
cigarette use.

Fall 2021
to Spring
2022

Clinical experts
Dr. Cynthia
Betron and Dr.
Joan Frizzell

Erika Dlugosz
and Lindsay
Gregg

A thorough assessment of
patient vaping history and
habits enables CRNA’s to
deliver a properly tailored
anesthetic plan of care
and provide ideal surgical
outcomes.

4. Collect
feedback from
an expert
review panel.

In conjunction with
resource toolkit materials,
present a first draft of our
focused preoperative
assessment of the surgical
vaping patient to
anesthesia providers
(anesthesiologists and
CRNA’s).

Fall 2021

Einstein Medical
Center
Montgomery
Department of
Anesthesiology

Erika Dlugosz
and Lindsay
Gregg

Following assessment
presentation, we will
solicit feedback from the
reviewers.

Perform quantitative and
qualitative analysis of
reviewer feedback.

Spring
2022

Einstein Medical
Center
Montgomery
Department of
Anesthesiology

Erika Dlugosz
and Lindsay
Gregg

Edits to the initial focused
assessment will be made
based off critiques from
the expert review panel.

Conduct a department inservice or poster
presentation detailing
adequate assessment of
patient vaping status and
current AANA
guidelines.

Spring
2022

Einstein Medical
Center
Montgomery
Department of
Anesthesiology

Erika Dlugosz
and Lindsay
Gregg

Administering the
anesthetic most suited to
patients who vape is
contingent upon
identifying electronic
cigarette use prior to
surgery.

Long-Term Objectives
1. Revise the
enhanced
preoperative
assessment of
the surgical
patient who
vapes.
2. Disseminate the
enhanced
preoperative
assessment of
the surgical
patient who
vapes.

Refer to Appendix 5.
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3. Implement the
enhanced
preoperative
assessment of
the surgical
patient who
vapes.

Surgical patients at
Einstein Medical Center
Montgomery will be
routinely assessed for
electronic cigarette use
before undergoing general
anesthesia.

TBD

Einstein Medical
Center
Montgomery

Future Frank
J. Tornetta
School of
Anesthesia
cohorts

Anesthesia providers will
have an increased
awareness of the
importance of questioning
patients about vaping and
adhere to AANA best
practices.
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Appendix 5
Expert Reviewer Content Form

Expert Validity Check
The following are enhanced assessment questions to be asked during a perioperative patient interview. Please read over each question and then, in
your opinion, determine the relevancy of each question as it pertains to assessment of electronic cigarette use in perioperative patients. Please also
include any relevant comments or suggestions.
1. Do you vape or use an
electronic cigarette device
like a JUUL?
2. How long have you used
vapes/e-cigarettes?

1 = Not at all
relevant

2 = Somewhat relevant

3 = Very
relevant

4 = Extremely
relevant

Comment

1 = Not at all
relevant

2 = Somewhat relevant

3 = Very
relevant

4 = Extremely
relevant

Comment

3. How often do you use
vapes/e-cigarettes?

1 = Not at all
relevant

2 = Somewhat relevant

3 = Very
relevant

4 = Extremely
relevant

Comment

4. When was the last time you
vaped?

1 = Not at all
relevant

2 = Somewhat relevant

3 = Very
relevant

4 = Extremely
relevant

Comment

5. What are the contents of
your vaping solution?
(nicotine, flavoring, etc.)

1 = Not at all
relevant

2 = Somewhat relevant

3 = Very
relevant

4 = Extremely
relevant

Comment
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Appendix 6
Directed Content Analysis for Learning Objectives

Code (behavioral)

Citation(s)

Screening Question

Addressing vaping/EC by other commonly used
terms

Harris & Foley, 2020

Do you vape or use an electronic cigarette
device like a JUUL?

Hobson et al., 2020
Oyston, 2020
Rusy et al. , 2021

Number of years vaping/ previous cigarette use

Oyston, 2020
Harris & Foley, 2020

How long have you used vapes / ecigarettes?

Hobson et. al, 2020

Frequency of use

Oyston, 2020

How often do you use vapes/e-cigarettes?

Harris & Foley, 2020

When was the last time you vaped?

Hobson et. al, 2020
Type/vaping substance

Oyston, 2020
Harris & foley, 2020
Hobson et, al, 2020

What are the contents of your vaping
solution (nicotine, flavoring, etc.)?
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Appendix 7
Qualtrics Survey Example
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Appendix 8
Item Content Validity Index

Question

Number of experts

Proportion in
agreement about
relevance

I-CVI

Comments

Do you vape or
use an electronic
cigarette device
like a JUUL?

5

5/5

1.0

“Important to know if patient uses this”

How long have
you used vapes/ecigarettes?

4

3/4

0.75

How often do you
use vapes/ecigarettes?

5

5/5

1.0

“I think it’s valuable to know how often they use this”

When was the last
time you vaped?

5

4/5

0.80

“I think it’s very good to know how recently they used it”

What are the
contents of your
vaping solution?
(nicotine,
flavoring, etc.)

5

4/5

0.80

“Most patients probably won’t know most of the ingredients
except nicotine, which is probably most important for the
anesthesia provider anyways”

“This is as relevant if not more relevant as asking a patient
about cigarette use. We ask this now so this is also just as
important.”
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Appendix 9
Resource Toolkit
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